Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - TOTAL CURRENT LIABILITIES
Total Current Liabilities HALO - Halozyme Therapeutics, Inc.
139 M
LAST VALUE
3.13%
2 YEAR CAGR
10.19%
5 YEAR CAGR
19.05%
10 YEAR CAGR